Guest Column
Bright prospects
- Published 20 Aug 2009
Mark Mobius, executive chairman of Templeton Asset Management, on the long-term promise of China's economy.
The China market offers many interesting opportunities and will potentially continue to grow with the Chinese economy. The November 2008 stimulus package has proved to be timely and successful in ensuring that economic growth in China remains strong. Efforts to stimulate domestic demand, first of all, through increased infrastructure spending boosted sectors such as cement, steel, and construction. A return in consumer confidence also saw a recovery in domestic demand for apartments and cars, with sales and profits recovering from the trough. Moreover, private investments have now started to catch up (for example, property companies have started to buy more land to replenish their land banks and they have also accelerated their property developments). Factors such as these will ensure that China remains one of the fastest growing major economies in the world. This in turn will support the stock market as well.
Login
If you are already a subscriber, please log in below.
China Confidential Funds
China Confidential Funds, a new research service launched by FT China Confidential, is dedicated to illuminating the mainland fund industry. Our team of fund industry experts in Shanghai search out the interesting trends in fund performance, strategy, interactions with overseas funds, regulatory changes, distribution and management. We also use a proprietary system to track the emerging flows of Chinese money. Click here to find out more.
Other Articles on this Issue
-
Macro View
A moment of truth
-
Funds Data
China zeal wavers
-
Forbidden City
Iron and awe
-
The Big Call
A local financial time bomb
-
Postcard From No 528
Wobbling on the liquidity high wire
-
Financial China
Insurance - a structural play
Ping An - not so tranquil
China Life - in the balance
-
Capital Intensive China
Developers defy doomsayers
-
The Best of Chinese Commentators
Inflation, inflation, inflation
Sovereign wealth
-
Consumer China
Pharmaceuticals - a healthy course
Sinovac and swine flu
Sinopharm - a new contender
Simcere – not immune
Tongrentang – TCM bellwether
- View issue
v5.0.24 running on fbweb09-uvuk-l
